Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3614951)

Published in PLoS One on April 02, 2013

Authors

Ana Gvozdenovic1, Matthias J E Arlt, Carmen Campanile, Patrick Brennecke, Knut Husmann, Walter Born, Roman Muff, Bruno Fuchs

Author Affiliations

1: Laboratory for Orthopedic Research, Department of Orthopedics, Balgrist University Hospital, Zurich, Switzerland.

Articles cited by this

CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01

CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol (2003) 9.13

Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65

Biology and therapeutic advances for pediatric osteosarcoma. Oncologist (2004) 3.34

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27

CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol (2004) 2.71

Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev (1998) 2.66

Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis (2007) 2.53

Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39

Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res (1993) 1.90

CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res (2005) 1.72

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res (1993) 1.68

Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol (1991) 1.66

RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci U S A (2004) 1.52

CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res (1997) 1.25

Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Curr Protein Pept Sci (2010) 1.21

Expression of CD44 in human lung tumors. Cancer Res (1994) 1.18

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem (1994) 1.16

Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest (2009) 1.05

Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res (2002) 1.02

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. Prostate (1998) 1.02

LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. J Orthop Res (2011) 1.01

Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol (2007) 1.00

Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation. J Biol Chem (2011) 0.97

Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp Cell Res (2005) 0.94

Transportin regulates nuclear import of CD44. J Biol Chem (2010) 0.94

CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res (1995) 0.94

Expression of CD44 variants in osteosarcoma. J Cancer Res Clin Oncol (1999) 0.93

Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer (1994) 0.91

Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases. Virchows Arch (2007) 0.87

HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells. Int J Oncol (2006) 0.86

Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med (2009) 0.86

Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma. Clin Orthop Relat Res (2002) 0.85

The NF2 gene and merlin protein in human osteosarcomas. Neurogenetics (1998) 0.85

Immunoexpression of Ezrin and CD44 in patients with osteosarcoma. J Pediatr Hematol Oncol (2010) 0.84

mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells. Photochem Photobiol (2012) 0.82

Merlin: the wizard requires protein stability to function as a tumor suppressor. Biochim Biophys Acta (2012) 0.82

Articles by these authors

International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev (2002) 2.86

The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. Int J Cancer (2012) 2.06

Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell (2008) 1.67

CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome. J Bone Miner Res (2013) 1.61

Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev (2005) 1.50

Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. Clin Orthop Relat Res (2008) 1.49

Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am (2004) 1.37

Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res (2005) 1.36

Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31

Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units. Tissue Eng (2006) 1.29

Novel measurement technique of the tibial slope on conventional MRI. Clin Orthop Relat Res (2009) 1.21

Adipogenic and myogenic gene expression in rotator cuff muscle of the sheep after tendon tear. J Orthop Res (2009) 1.18

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem (2006) 1.13

Reconstruction after total sacrectomy: early experience with a new surgical technique. Clin Orthop Relat Res (2005) 1.11

Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J Biol Chem (2004) 1.10

Relationship between surgical margins and local recurrence in sarcomas of the spine. Clin Orthop Relat Res (2002) 1.07

Identification of potential chemoresistance genes in osteosarcoma. Anticancer Res (2008) 1.06

Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog (2008) 1.05

Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest (2009) 1.05

Bowel and bladder function after major sacral resection. Clin Orthop Relat Res (2002) 1.04

CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis (2014) 1.04

High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis. Clin Cancer Res (2006) 1.01

LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. J Orthop Res (2011) 1.01

Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs (2007) 1.00

Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J Bone Miner Res (2012) 0.99

The patella morphology in trochlear dysplasia--a comparative MRI study. Knee (2006) 0.97

The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry (2005) 0.95

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene (2002) 0.95

Physeal distraction for joint preservation in malignant metaphyseal bone tumors in children. Clin Orthop Relat Res (2011) 0.94

The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor. Biochemistry (2002) 0.93

Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines. Invest New Drugs (2007) 0.91

Femoral stress fracture after computer navigated total knee arthroplasty. Knee (2006) 0.90

Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice. Biochim Biophys Acta (2013) 0.89

Expression of atrophy mRNA relates to tendon tear size in supraspinatus muscle. Clin Orthop Relat Res (2008) 0.89

Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes. Peptides (2004) 0.89

Antimetastatic activity of honokiol in osteosarcoma. Cancer (2011) 0.89

Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochim Biophys Acta (2012) 0.89

Transgenic mice with ocular overexpression of an adrenomedullin receptor reflect human acute angle-closure glaucoma. Clin Sci (Lond) (2008) 0.88

Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice. PLoS One (2013) 0.86

Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems. Sarcoma (2012) 0.86

Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis. J Gene Med (2004) 0.85

Extensor function after medial gastrocnemius flap reconstruction of the proximal tibia. Clin Orthop Relat Res (2013) 0.85

Self-assembly of sensory neurons into ganglia-like microtissues. J Biotechnol (2005) 0.85

The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptide. FEBS Lett (2002) 0.85

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity. Thromb Haemost (2005) 0.85

Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice. Hypertension (2009) 0.84

Extraarticular knee resection for sarcomas with preservation of the extensor mechanism: surgical technique and review of cases. Clin Orthop Relat Res (2010) 0.83

ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2. BMC Cancer (2014) 0.83

A new method for repeated drug infusion into the femoral artery of mice. J Am Assoc Lab Anim Sci (2012) 0.82

Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of the mouse calcitonin-like receptor. J Biol Chem (2004) 0.82

Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. Biochem Pharmacol (2003) 0.82